Biomass fuel use and the risk of asthma in Nigerian children

Jesse D Thacher1, Anders Emmelin, Aboi J K Madaki

  • 1Institute of Environmental Medicine, Karolinska Institutet, Nobels Väg 13, 17177 Stockholm, Sweden.

Respiratory Medicine
|October 8, 2013
PubMed

Insights

Biomass fuel smoke exposure in Nigerian children was not linked to increased asthma symptoms or airway obstruction. However, lifetime smoke exposure may affect lung function in females and older children.

Area of Science:

  • Environmental Health
  • Pediatric Respiratory Medicine
  • Epidemiology

Background:

  • Biomass fuel smoke exposure is a known risk factor for childhood respiratory infections.
  • The association between biomass fuel smoke and childhood asthma remains unclear.
  • This study investigated biomass fuel use and its impact on asthma in Nigerian children.

Purpose of the Study:

  • To examine the relationship between biomass fuel use and asthma symptoms in Nigerian children.
  • To assess the association between biomass fuel smoke exposure and lung function (airway obstruction) in this population.
  • To identify potential risk factors for asthma in children exposed to biomass fuel smoke.

Main Methods:

  • A cross-sectional study involving 299 children aged 5-11 years in North Central Nigeria.
  • Data collection included cooking fuel types, daily smoke exposure duration, and asthma symptoms via a modified ISAAC questionnaire.
  • Lung function was evaluated using spirometry to measure forced expiratory volume in 1 second (FEV1) and forced expiratory volume in 6 seconds (FEV6).

Main Results:

  • The prevalence of a lifetime history of wheeze was 9.4%, and 4.7% of children exhibited airway obstruction.
  • Female children had significantly lower predicted FEV1 and FEV6 values compared to males.
  • Advancing age was associated with a decline in predicted FEV1.
  • No significant association was found between daily firewood use and increased asthma symptoms or airway obstruction.

Conclusions:

  • Daily biomass fuel smoke exposure was not significantly associated with increased asthma symptoms or airway obstruction in Nigerian children.
  • Lifetime smoke exposure might contribute to reduced spirometric values observed in female subjects and with increasing age.
  • Further research is needed to elucidate the long-term respiratory effects of biomass fuel smoke exposure in vulnerable populations.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Biofuels01:25

Biofuels

The microbial conversion of organic matter into biofuels holds potential as a renewable energy source. Among biofuel sources, microalgae are recognized as a highly efficient and adaptable feedstock for biodiesel production, owing to their rapid biomass accumulation, elevated lipid productivity, and capacity to proliferate in diverse aquatic systems, including freshwater, marine, and wastewater habitats. Unlike terrestrial crops, microalgae do not compete for land and can achieve significantly...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...